Mechanism of Action: RNA Synthetase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: RNA Synthetase Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Israel | MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 065123-001 | Nov 7, 2003 | AB | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Encube | MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 213076-001 | Aug 31, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Glenmark Pharms | MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 090480-001 | Jun 8, 2011 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Alembic | MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 213053-001 | Nov 16, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Glenmark Pharms Inc | MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 201587-001 | Jan 24, 2013 | AB | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Teva | MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 065085-001 | Nov 7, 2003 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Amneal | MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 214811-001 | Nov 15, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
